To earn CME related to this news article, click here. March 20, 2009 — Routine use of B-type natriuretic peptide (BNP) testing in all severely dyspneic patients in the emergency department is not ...

Vienna, Austria - A randomized trial of B-type natriuretic peptide (BNP) testing vs standard clinical assessment for patients presenting with dyspnea shows that the addition of the test reduces the ...

Dallas, TX - More utility for a rapid assay for B-natriuretic peptide (BNP) has been reported in two studies published this month. In one, which appears in the February 5, 2002 issue of Circulation, ...

Sulfonylureas Up Cardio Events Versus Metformin Screening people at risk for heart failure for certain levels of brain-type natriuretic peptide (BNP) reduces the risk of left ventricle dysfunction and ...

Secondary to hypertension, ventricular hypertrophy and remodeling are frequent causes of diastolic heart failure (HF), a condition associated with morbidity, hospitalization and mortality. Diagnosing ...

ATLANTA - In a trial of nearly 1,600 patients in the United States and Europe, a 15-minute blood test enabled emergency-room doctors to correctly diagnose congestive heart failure in 9 out of 10 cases ...

Heart failure is the fastest rising diagnostic condition in modern cardiology today. In the US alone, approximately one million new patients are diagnosed with heart failure each year. Many of these ...

(MENAFN- EIN Presswire) EINPresswire/ -- The global BNP and NTproBNP market was valued at $1.1 billion in 2021 and is projected to reach $3.4 billion by 2031, registering a robust CAGR of 12.2% from ...